BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3106484)

  • 1. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells.
    Muñoz E; Zubiaga AM; Sims JE; Huber BT
    J Immunol; 1991 Jan; 146(1):136-43. PubMed ID: 1845804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
    Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
    Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
    J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.
    Minami Y; Oishi I; Liu ZJ; Nakagawa S; Miyazaki T; Taniguchi T
    J Immunol; 1994 Jun; 152(12):5680-90. PubMed ID: 8207200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL; Evans SW; Rapp UR; Cleveland JL
    J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
    Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K
    Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T; Bravo R; Müller R
    Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression.
    Hardt C
    Eur J Immunol; 1987 Dec; 17(12):1711-7. PubMed ID: 3121357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 induces protein tyrosine phosphorylation in T cells.
    Muñoz E; Zubiaga A; Huang C; Huber BT
    Eur J Immunol; 1992 Jun; 22(6):1391-6. PubMed ID: 1376256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.